1.0株式会社マイクロンhttps://microncro.cominfo@digitalcube.jphttps://microncro.com/archives/post/author/infodigitalcube-jp/Video broadcasting “FDA Guidance Part 2, Micron’s experience” | Micron, Inc. | Molecular Imaging CRO Networkrich600338<blockquote class="wp-embedded-content" data-secret="lSC3v92CRW"><a href="https://microncro.com/en/archives/post/video-fda-guidance-part-2/">Video broadcasting “FDA Guidance Part 2, Micron’s experience”</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://microncro.com/en/archives/post/video-fda-guidance-part-2/embed/#?secret=lSC3v92CRW" width="600" height="338" title="“Video broadcasting “FDA Guidance Part 2, Micron’s experience”” — 株式会社マイクロン" data-secret="lSC3v92CRW" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script>
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://microncro.com/wp-includes/js/wp-embed.min.js
</script>
In this video we briefly explain the overview of FDA Guidance, Clinical Trial Imaging Endpoint Process Standards continuing from last time. In addition, we introduce our experience how we organize high quality imaging study. FDA Guidance Clinical Trial Imaging Endpoint Process Standards Part2 -Micron’s experience-https://microncro.com/wp-content/uploads/2026/05/OGP_W1200_H630.png1200630